A carregar...
Plasminogen Activator Inhibitor and the Risk of Cardiovascular Disease: The Framingham Heart Study
INTRODUCTION: Although plasminogen activator inhibitor (PAI-1) plays a key regulatory role in fibrinolysis, it has not been clearly shown to independently predict cardiovascular disease (CVD) among individuals without prior CVD. We investigated, in the Framingham Heart Study offspring cohort, whethe...
Na minha lista:
| Publicado no: | Thromb Res |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722217/ https://ncbi.nlm.nih.gov/pubmed/26896607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2016.02.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|